Isabel Mir-Viladrich

Isabel Mir-Viladrich

Auto-generated profile, based on publicly available information

Isabel Mir-Viladrich

Programa Integrado de Investigación en Tuberculosis (PII TB) de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR), Barcelona, Spain

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2013 in BMC Family Practice
Verified
Journal Article
Open access
PDF file
MRMiguel Roman-Rodriguez
Miguel Roman-Rodriguez
CLConcepción Larraz
Concepción Larraz
AGAmalia Gómez
Amalia Gómez
JRJoana Ripoll
Joana Ripoll
IMIsabel Mir
Isabel Mir
MEMagdalena Esteva
Magdalena Esteva
Background: Pulmonary Rehabilitation for moderate Chronic Obstructive Pulmonary Disease in primary care could improve patients’ quality of life. Methods: This study aimed to assess the efficacy of a 3-month Pulmonary Rehabilitation (PR) program with a further 9 months of maintenance (RHBM group) compared with both PR for 3 months without further maintenance (RHB group) and usual care in improving the quality of life of patients with moderate COPD. We conducted a parallel-group, randomized clinical trial in Majorca primary health care in which 97 patients with moderate COPD were assigned to the 3 groups. Health outcomes were quality of life, exercise capacity, pulmonary function and exacerbations. Results: We found statistically and clinically significant differences in the three groups at 3 months in the emotion dimension (0.53; 95%CI0.06-1.01) in the usual care group, (0.72; 95%CI0.26-1.18) the RHB group (0.87; 95%CI 0.44-1.30) and the RHBM group as well as in fatigue (0.47; 95%CI 0.17-0.78) in the RHBM group. After 1 year, these differences favored the long-term rehabilitation group in the domains of fatigue (0.56; 95%CI 0.22-0.91), mastery (0.79; 95%CI 0.03-1.55) and emotion (0.75; 95%CI 0.17-1.33). Between-group analysis only showed statistically and clinically significant differences between the RHB group and control group in the dyspnea dimension (0.79 95%CI 0.05-1.52). No differences were found for exacerbations, pulmonary function or exercise capacity. Conclusions: We found that patients with moderate COPD and low level of impairment did not show meaningful changes in QoL, exercise tolerance, pulmonary function or exacerbation after a one-year, community based rehabilitation program. However, long-term improvements in the emotional, fatigue and mastery dimensions (within intervention groups) were identified. Trial registration: ISRCTN94514482

1 January 2016 in Archivos de Bronconeumología
Verified
Journal Article
Closed access
IVIsabel Mir Viladrich
Isabel Mir Viladrich
ETEsteban Daudén Tello
Esteban Daudén Tello
GSGuillermo Solano-López
Guillermo Solano-López
FLFrancisco Javier López Longo
Francisco Javier López Longo
CSCarlos Taxonera Samso
Carlos Taxonera Samso
JGJosé Maria García García
José Maria García García

1 January 2014 in Respiratory Research
Verified
Journal Article
Open access
PDF file
CCCiro Casanova
Ciro Casanova
JMJose M. Marin
Jose M. Marin
CMCristina Martinez-Gonzalez
Cristina Martinez-Gonzalez
PLPilar de Lucas-Ramos
Pilar de Lucas-Ramos
IMIsabel Mir-Viladrich
Isabel Mir-Viladrich
FCfor the COPD History Assessment In SpaiN (CHAIN) cohort
for the COPD History Assessment In SpaiN (CHAIN) cohort
Rationale: Little is known about the longitudinal changes associated with using the 2013 update of the multidimensional GOLD strategy for chronic obstructive pulmonary disease (COPD).

14 September 2016 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
SGSmoking and Tuberculosis Research Working Group
Smoking and Tuberculosis Research Working Group
MJMaría Ángeles Jiménez-Fuentes
María Ángeles Jiménez-Fuentes
TRTERESA RODRIGO
TERESA RODRIGO
MAMaría Neus Altet
María Neus Altet
CJCarlos A. Jiménez-Ruiz
Carlos A. Jiménez-Ruiz
JCJoan A. Caylà
Joan A. Caylà
To determine the prevalence of smoking and analyze associated factors in a cohort of patients diagnosed with tuberculosis (TB) in Spain between 2006 and 2013. Multicenter, cross-sectional, descriptive, observational study using a national database of TB patients, using logistic regression to calculate odds ratios (OR) and confidence intervals (CI). We analyzed 5,846 cases (62 % men, mean age 39 years, 33 % foreigners). 23.4 % were alcohol abuser, 1.3 % were injected drug users (IDU), 4.6 % were co-infected with HIV, and 7.5 % had a history of TB treatment. 6.6 % and 0.8 % showed resistance to one and multiple drugs, respectively. The predominant clinical presentation was pulmonary (71 %) with a cavitary radiological pattern in 32.8 % of cases. 82 % of cases were confirmed microbiologically, and 54 % were smear-positive microscopy. 2,300 (39.3 %) patients were smokers. The following factors were associated with smoking: male sex (OR = 2.26;CI:1.97;2.60), Spanish origin (OR = 2.79;CI:2.40–3.24), alcoholism (OR = 2.85;CI:2.46;3.31), IDU (OR = 2.78;CI:1.48;5.52), homelessness (OR = 1.99;CI:1.14–3.57), pulmonary TB (OR = 1.61;CI:1.16;2.24), cavitary radiological pattern (OR = 1.99;CI:1.43;2.79) and a smear-positive microscopy at the time of diagnosis (OR = 1.39;CI:1.14;1.17). The prevalence of smoking among TB patients is high. Smokers with TB have a distinct sociodemographic, clinical, radiological and microbiological profile to non-smokers.

11 December 2014 in Respiratory Research
Verified
Journal Article
Open access
PDF file
TCthe COPD History Assessment In SpaiN (CHAIN) cohort
the COPD History Assessment In SpaiN (CHAIN) cohort
CCCiro Casanova
Ciro Casanova
JMJose M. Marin
Jose M. Marin
CMCristina Martinez-Gonzalez
Cristina Martinez-Gonzalez
PLPilar de Lucas-Ramos
Pilar de Lucas-Ramos
JDJuan Pablo De-Torres
Juan Pablo De-Torres